Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
source: pixabay.com
The American Journal of Managed Care (AJMC) published excerpts from a presentation by Dr. Andrew Wei at the 61st American Society of Hematology (ASH) Annual Meeting. The article stated…
Continue Reading
Phase III Study for Acute Myeloid Leukemia Hailed as Landmark Trial
source: pixabay.com
According to a recent article in Pharma Tutor, researchers at NHGRI, a division of the National Institute of Health, identified the biological cause of a newly-discovered autoinflammatory disease they named…
Continue Reading
ICYMI: A New Year, a New Autoinflammatory Disease, and a Promising New Drug
source: pixabay.com
According to a recent article in Yahoo News, Johan’s mother’s seven-year-old brother died years ago of chronic granulomatous disease (CGD). The mother, Maren, was told that she also had…
Continue Reading
A Bone Marrow Transplant From His Six-Year-Old Brother Saved This CGD Patient’s Life
Ty Eschenbaum’s world of high school football and working on his family’s ranch and farm changed suddenly after his freshman year when he was diagnosed with leukemia. Ty, who…
Continue Reading
Leukemia Survivor Arranges Make-a-Wish Trip for a Young Caroli Disease Patient
source: pixabay.com
According to an article in BioSpace, the FDA recently approved the PARP inhibitor Lynparza that was developed by Merck and AstraZeneca to be used as maintenance therapy for pancreatic…
Continue Reading
2020 Brings Hope to Patients with Pancreatic Cancer Thanks to Newly Approved Lynparza
source: pixabay.com
Susan Winn’s family history of ovarian and breast cancer can be traced back to the 1860s. Susan’s adult daughters, Kathryn, Bridget and Maureen, were recently interviewed with CURE® (Cancer Updates Research…
Continue Reading
A Family With the Most Significant History of Breast and Ovarian Cancer in the US
source: pixabay.com
An article published earlier this year by Fierce Biotech outlines an approach that was developed by researchers at the Fred Hutchinson Cancer Research Center. Using CRISPR-Cas9’s gene-editing method the researchers were…
Continue Reading
New Approach Uses CRISPR-Cas9 to Boost Fetal Hemoglobin Production to Treat Blood Disorders
According to a recent article in Euronews, this year one hundred children who were diagnosed with spinal muscular atrophy (SMA) will receive Zolgensma, the world’s highest-priced drug, at no cost.…
Continue Reading
Parents React to Novartis’ International “Baby Lottery” for Zolgensma with Hope But Also With Outrage
source: pixabay.com
According to recent articles in Runner’s World Magazine, having a diagnosis of multiple sclerosis has not stopped Cheryl Hile, Jennifer Lee or Melissa Ossanna. Each woman is fighting the symptoms…
Continue Reading
Three Courageous Women With Multiple Sclerosis are Fighting the Disease by Running Marathons.
According to the UK’s National Institute for Health Research (NIHR), a new technology called machine perfusion (MP) has the potential to solve organ shortage, a major challenge in liver transplantation.…
Continue Reading
Liver Transplants Are Vastly Improved By A New Technology
An open letter to The Editor from Gaetani et al was recently published in the Orphanet Journal of Rare Diseases. Dr. Gaetani and associates at the Fondazione Policlinico Universitario, Rome Italy,…
Continue Reading
Outcomes Differ in Studies Conducted for Hereditary Hemorrhagic Telangiectasia (HHT)
Pfizer issued a statement this week through its Media Relations that its drug VYNDAQEL® for treatment of Transthyretin Amyloid Cardiomyopathy received positive opinion by the European Medicines Agency’s (EMA) Committee for…
Continue Reading
VYNDAQEL® for treatment of Transthyretin Amyloid Cardiomyopathy Received Positive Opinion by the (EMA)
Tahnee Hamilton was recently interviewed by KSL-TV about her young child, Avery, who was diagnosed less than a year ago with T Cell Acute Lymphoblastic Leukemia. About Veno-Occlusive disease (VOD) Avery…
Continue Reading
Donors are Needed Due To A Shortage of Platelets That Threatens A Young Child’s Life
CNN reported details of Ed’s illness as related by his fiancée Katy Berteau, who remained at this side continually despite risking her own health. Katy and Ed had planned to…
Continue Reading
ESPN Reporter Edward Aschoff Died On Christmas Eve, His 34th Birthday, of a Rare Disease
source: pixabay.com
According to a recently published article in Targeted Oncology, the results of the Phase III CANDOR trial were presented at the 61st ASH annual conference in Orlando, Florida. The…
Continue Reading
This Three Drug Combination for Multiple Myeloma Looks Promising
A recent article published in Globe Newswire heralded Marinus Pharmaceuticals’ new drug, ganaxolone. The drug has been studied in over 1600 patients and is now being tested in two clinical…
Continue Reading
Rare Epilepsy Updates: One New Drug, Two Clinical Trials, and Orphan Drug Designation
At times there seems to be no happy medium in life. A recent article in Bloomberg claims that the speed at which the FDA is approving newly developed drugs is…
Continue Reading
Is the FDA Approving Drugs too Quickly?
Since most people cannot truly understand the challenges faced by a blind person, then an artist who cannot see is unimaginable. According to a recent article in the British…
Continue Reading
A Blind Artist, A Motivational Speaker Who Can’t Talk, and a Single Mom with Rheumatoid Arthritis
When the Leukemia & Lymphoma Society (LLS) was founded in 1949 by a family in memory of their sixteen-year-old son, cancer was considered a hopeless condition. As noted recently…
Continue Reading
Pediatric Cancer and the 70th Anniversary of the Leukemia & Lymphoma Society
According to a recent article in the ASH Clinical News patients are being encouraged to participate in shared decision-making (SDM) with their doctors, nurses and other medical personnel. The…
Continue Reading
A New Patient-Centered World is Emerging in Hematology
source: pixabay.com
Encouraging results from a clinical study were reported recently in Science & Enterprise describing a treatment for ALS using stem cells extracted from a patient’s bone marrow. The clinical…
Continue Reading
A New Experimental Treatment Brings Improvement to ALS Patients
source: pixabay.com
A recent article in Bloomberg’s SFGate focused on the price of drugs. The average patient cannot afford the price of many drugs now on the market. Insurance companies have…
Continue Reading
Four Doctors Who Worked on the Development of Tafamidis Criticize its Price
On Dec 3, 2019 Share A blind artist, a motivational speaker who can’t speak and a young mom with arthritis: These are just three of the British Columbians shattering stereotypes…
Continue Reading
Meet 3 British Columbians shattering stereotypes about their disabilities – My City News
A recent article in the Taunton Gazette describes the dilemma faced by the parents of four-year-old Jaxtien Miller who is a metachromatic leukodystrophy patient waiting for a stem cell…
Continue Reading
After Five Insurance Coverage Denials, the Next Appeal Brought a Young Patient Closer to Receiving Treatment for Metachromatic Leukodystrophy
source: pixabay.com
A recent article in BioPortfolio carried AstraZeneca’s announcement of the FDA’s approval of CALQUENCE® (acalabrutinib) for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The approval…
Continue Reading
IYCMI: CALQUENCE Has Received US FDA Approval to Benefit Adults with CLL